Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
08/03/2022* -- Results Q2 2022 -- 0.49 --
08/03/2022* 11:00 EST Earnings Call Q2 2022 -- -- --
05/09/2022 -- Results Q1 2022 0.27 0.39 -31.23%
05/09/2022 11:00 EST Earnings Call Q1 2022 -- -- --
02/28/2022 -- Results Q4 2021 0.35 0.32 9.71%
02/28/2022 11:00 EST Earnings Call Q4 2021 -- -- --
11/04/2021 -- Results Q3 2021 0.20 0.25 -18.64%
11/04/2021 11:00 EST Earnings Call Q3 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 08/03/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 05/09/2022
Beat/Miss Upgrade
Return Since 11.86%
Last FQE 03/31/2022
Next FQE 06/30/2022

Profile

Edit
Heska Corp is engaged in developing, manufacturing, marketing, selling & supporting veterinary products. The company's segments are Core Companion Animal Health & Other Vaccines, Pharmaceuticals and Products. The CCA segment includes, primarily for canine & feline use, a point of care laboratory instruments & supplies, digital imaging products, software & services, local & cloud-based data services, allergy testing & immunotherapy, & single-use offerings such as point of care diagnostic tests and heartworm preventive products. The OVP segment includes private label vaccine and pharmaceutical production, primarily for cattle but also for other species including equine, porcine, avian, feline & canine.
URL https://www.heska.com
Investor Relations URL https://ir.heska.com/
HQ State/Province Colorado
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Growth
Next Earnings Release Aug. 03, 2022 (est.)
Last Earnings Release May. 09, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Sep. 26, 2012

Dividends

Dividend Per Share (TTM) 0.00
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market --
Yield to Sector --
Yield to Industry --
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date Sep. 26, 2012
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
113.3%
85.11%
12.03%
7.34%
11.43%
51.81%
25.29%
-44.86%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-17.67%
15.38%
1.56%
-35.67%
-38.44%
161.9%
-17.93%
-19.28%
-20.38%
79.59%
-42.99%
105.1%
-27.79%
21.19%
140.9%
-5.85%
10.22%
32.33%
-32.38%
2.42%
-0.65%
0.53%
28.66%
30.72%
4.69%
14.34%
-3.23%
47.78%
-78.45%
198.8%
23.35%
-21.14%
-64.47%
As of May 20, 2022.

Profile

Edit
Heska Corp is engaged in developing, manufacturing, marketing, selling & supporting veterinary products. The company's segments are Core Companion Animal Health & Other Vaccines, Pharmaceuticals and Products. The CCA segment includes, primarily for canine & feline use, a point of care laboratory instruments & supplies, digital imaging products, software & services, local & cloud-based data services, allergy testing & immunotherapy, & single-use offerings such as point of care diagnostic tests and heartworm preventive products. The OVP segment includes private label vaccine and pharmaceutical production, primarily for cattle but also for other species including equine, porcine, avian, feline & canine.
URL https://www.heska.com
Investor Relations URL https://ir.heska.com/
HQ State/Province Colorado
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Growth
Next Earnings Release Aug. 03, 2022 (est.)
Last Earnings Release May. 09, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Sep. 26, 2012

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
TMFS 3.547M USD 4.23%
BBHSX 13.83M USD 3.48%
TCGRX 11.17M USD 2.52%
AOFCX 118.37M USD 2.46%
CCRIX 51.88M USD 2.38%
PAWZ 4.126M USD 2.16%
GNSRX 18.41M USD 1.87%
GPGOX 8.227M USD 0.88%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter HSKA Tweets